posted on 2019-07-24, 13:19authored byL Furi, LA Crawford, G Rangel-Pineros, AS Manso, M De Ste Croix, RD Haigh, MJ Kwun, K Engelsen Fjelland, GD Gilfillan, SD Bentley, NJ Croucher, MR Clokie, MR Oggioni
Virus-host interactions are regulated by complex co-evolutionary dynamics. In S. pneumoniae phase-variable Type I restriction modification (R-M) systems are part of the core genome. We hypothesised that the ability of the R-M systems to switch between six target DNA specificities also has a key role in preventing the spread of bacteriophages. Using the streptococcal temperate bacteriophage SpSL1, we showed that the variants of both the SpnIII and SpnIV R-M system were able to restrict invading bacteriophage proportional to the number of target sites in the bacteriophage genome. In addition to restriction of lytic replication SpnIII also led to abortive infection in the majority of host cells. During lytic infection, transcriptional analysis found evidence of phage-host interaction through the strong upregulation of the nrdR nucleotide biosynthesis regulon. During lysogeny, the phage had less effect on host gene regulation. This research demonstrates a novel combined bacteriophage restriction and abortive infection mechanism, highlighting the importance that the phase-variable Type I R-M systems have in the multi-functional defence against bacteriophage infection in the respiratory pathogen S. pneumoniae.Importance With antimicrobial drug resistance becoming an increasing burden on human health, much attention has been focussed on the potential use of bacteriophages and their enzymes as therapeutics. However, the investigations into the physiology of the complex interactions of bacteriophages with their hosts has attracted far less attention in comparison. This work describes the molecular characterisation of the infectious cycle of a bacteriophage of the important human pathogen Streptococcus pneumoniae and explores the intricate relationship between phase variable host defence mechanisms and the virus. This is the first report showing how a phase variable type I restriction modification system is involved in bacteriophage restriction, whilst also providing an additional level of infection control through abortive infection.
Funding
We thank the staff of the Medical Microbiology Laboratory at
Aberdeen Royal Infirmary for their dedicated support to this study.
We thank the Oxford Genomics Centre at the Wellcome Centre
for Human Genetics (funded by Wellcome Trust, United Kingdom
grant reference 203141/Z/16/Z) for the generation and initial processing of the sequencing data.
This study received funding from the NHS Grampian Endowment Fund through the Clinical Microbiology Fund reference number NER11553.
History
Citation
Journal of Bacteriology, 2019
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/Biological Sciences/Genetics and Genome Biology